CLINICAL RESEARCH: CARDIAC IMAGING
Late Gadolinium Enhancement by Cardiovascular Magnetic Resonance Heralds an Adverse Prognosis in Nonischemic Cardiomyopathy
Katherine C. Wu, MD, FACC*,*,
Robert G. Weiss, MD*, ,
David R. Thiemann, MD*, ,
Kakuya Kitagawa, MD*,
André Schmidt, MD*,
Darshan Dalal, MD*,
Shenghan Lai, MD, PhD ,
David A. Bluemke, MD, PhD*, ,
Gary Gerstenblith, MD, FACC*,
Eduardo Marbán, MD, PhD, FACC*,
Gordon F. Tomaselli, MD, FACC and
João A.C. Lima, MD, FACC*,
* Division of Cardiology, Department of Medicine, Johns Hopkins Medical Institutions, Baltimore, Maryland
Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland
Department of Radiology, Johns Hopkins Medical Institutions, Baltimore, Maryland
Department of Epidemiology, Johns Hopkins Medical Institutions, Baltimore, Maryland.
Manuscript received November 27, 2007;
revised manuscript received March 13, 2008,
accepted March 17, 2008.
* Reprint requests and correspondence: Dr. Katherine C. Wu, Division of Cardiology, Johns Hopkins Hospital, 600 North Wolfe Street/Carnegie 568, Baltimore, Maryland 21287. (Email: kwu{at}jhmi.edu).
Objectives: We examined whether the presence and extent of late gadolinium enhancement (LGE) by cardiovascular magnetic resonance (CMR) predict adverse outcomes in nonischemic cardiomyopathy (NICM) patients.
Background: Morbidity and mortality is high in NICM patients. However, the clinical course of an individual patient is unpredictable and current risk stratification approaches are limited. Cardiovascular magnetic resonance detects myocardial fibrosis, which appears as LGE after contrast administration and may convey prognostic importance.
Methods: In a prospective cohort study, 65 NICM patients with left ventricular (LV) ejection fraction 35% underwent CMR before placement of an implantable cardioverter-defibrillator (ICD) for primary prevention of sudden cardiac death. The CMR images were analyzed for the presence and extent of LGE and for LV function, volumes, and mass. Patients were followed for an index composite end point of 3 cardiac events: hospitalization for heart failure, appropriate ICD firing, and cardiac death.
Results: A total of 42% (n = 27) of patients had CMR LGE, averaging 10 ± 13% of LV mass. During a 17-month median follow-up, 44% (n = 12) of patients with LGE had an index composite outcome event versus only 8% (n = 3) of those without LGE (p < 0.001 for Kaplan-Meier survival curves). After adjustment for LV volume index and functional class, patients with LGE had an 8-fold higher risk of experiencing the primary outcome (hazard ratio 8.2, 95% confidence interval 2.2 to 30.9; p = 0.002).
Conclusions: A CMR LGE in NICM patients strongly predicts adverse cardiac outcomes. The CMR LGE may represent the end-organ consequences of sustained adrenergic activation and adverse LV remodeling, and its identification may significantly improve risk stratification strategies in this high risk population. (Imaging Techniques for Identifying Factors of Sudden Cardiac Death Risk; NCT00181233
[ClinicalTrials.gov]
)
|
Abbreviations and Acronyms
| | CMR = cardiovascular magnetic resonance | | HF = heart failure | | ICD = implantable cardioverter-defibrillator | | LGE = late gadolinium enhancement | | LV = left ventricular | | LVEDV = left ventricular end-diastolic volume | | LVEF = left ventricular ejection fraction | | NICM = nonischemic cardiomyopathy | | NYHA = New York Heart Association | | SCD = sudden cardiac death | | SI = signal intensity |
|
Related Article
-
Inside This Issue of JACC
J. Am. Coll. Cardiol. 2008 51: A31-A32.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
G. E. Leenders, J. Lumens, M. J. Cramer, B. W. L. De Boeck, P. A. Doevendans, T. Delhaas, and F. W. Prinzen
Septal Deformation Patterns Delineate Mechanical Dyssynchrony and Regional Differences in Contractility: Analysis of Patient Data Using a Computer Model
Circ Heart Fail,
January 1, 2012;
5(1):
87 - 96.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. M. Elliott and S. A. Mohiddin
Almanac 2011: cardiomyopathies. The national society journals present selected research that has driven recent advances in clinical cardiology
Heart,
December 1, 2011;
97(23):
1914 - 1919.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-M. Park, Y.-H. Kim, C.-M. Ahn, S.-J. Hong, D.-S. Lim, and W.-J. Shim
Relationship between ultrasonic tissue characterization and myocardial deformation for prediction of left ventricular reverse remodelling in non-ischaemic dilated cardiomyopathy
Eur Heart J Cardiovasc Imaging,
December 1, 2011;
12(12):
887 - 894.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. F. Ismail, S. K. Prasad, and D. J. Pennell
Prognostic importance of late gadolinium enhancement cardiovascular magnetic resonance in cardiomyopathy
Heart,
November 29, 2011;
(2011)
heartjnl-2011-300814v1.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. P. Leong, A. Chakrabarty, N. Shipp, P. Molaee, P. L. Madsen, L. Joerg, T. Sullivan, S. G. Worthley, C. G. De Pasquale, P. Sanders, et al.
Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography
Eur. Heart J.,
November 1, 2011;
(2011)
ehr391v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Klem, D. J. Shah, R. D. White, D. J. Pennell, A. C. van Rossum, M. Regenfus, U. Sechtem, P. R. Schvartzman, P. Hunold, P. Croisille, et al.
Prognostic Value of Routine Cardiac Magnetic Resonance Assessment of Left Ventricular Ejection Fraction and Myocardial Damage: An International, Multicenter Study
Circ Cardiovasc Imaging,
November 1, 2011;
4(6):
610 - 619.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. Messroghli, S. Nordmeyer, T. Dietrich, O. Dirsch, E. Kaschina, K. Savvatis, D. O h-Ici, C. Klein, F. Berger, and T. Kuehne
Assessment of Diffuse Myocardial Fibrosis in Rats Using Small-Animal Look-Locker Inversion Recovery T1 Mapping
Circ Cardiovasc Imaging,
November 1, 2011;
4(6):
636 - 640.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Sasaki, R. Hansford, M. M. Zviman, A. Kolandaivelu, D. A. Bluemke, R. D. Berger, H. Calkins, H. R. Halperin, and S. Nazarian
Quantitative Assessment of Artifacts on Cardiac Magnetic Resonance Imaging of Patients With Pacemakers and Implantable Cardioverter-Defibrillators
Circ Cardiovasc Imaging,
November 1, 2011;
4(6):
662 - 670.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Nucifora, G. D. Aquaro, and M. Lombardi
Cardiac magnetic resonance for early detection and risk stratification of patients with non-compaction cardiomyopathy: reply
Eur J Heart Fail,
October 1, 2011;
13(10):
1154 - 1154.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. G. Assomull, C. Shakespeare, P. R. Kalra, G. Lloyd, A. Gulati, J. Strange, W. M. Bradlow, J. Lyne, J. Keegan, P. Poole-Wilson, et al.
Role of Cardiovascular Magnetic Resonance as a Gatekeeper to Invasive Coronary Angiography in Patients Presenting With Heart Failure of Unknown Etiology
Circulation,
September 20, 2011;
124(12):
1351 - 1360.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Nazarian
Is Ventricular Arrhythmia a Possible Mediator of the Association Between Aortic Stenosis-Related Midwall Fibrosis and Mortality?
J. Am. Coll. Cardiol.,
September 13, 2011;
58(12):
1280 - 1282.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Iles, H. Pfluger, L. Lefkovits, M. J. Butler, P. M. Kistler, D. M. Kaye, and A. J. Taylor
Reply
J. Am. Coll. Cardiol.,
September 6, 2011;
58(11):
1194 - 1195.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Alter, H. Rupp, P. Adams, F. Stoll, J. H. Figiel, K. J. Klose, M. B. Rominger, and B. Maisch
Occurrence of late gadolinium enhancement is associated with increased left ventricular wall stress and mass in patients with non-ischaemic dilated cardiomyopathy
Eur J Heart Fail,
September 1, 2011;
13(9):
937 - 944.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. D. Karamitsos and S. Neubauer
The interplay between cardiac strain and fibrosis in non-ischaemic cardiomyopathies: insights from cardiovascular magnetic resonance
Eur J Heart Fail,
September 1, 2011;
13(9):
927 - 928.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Eitel, F. von Knobelsdorff-Brenkenhoff, P. Bernhardt, I. Carbone, K. Muellerleile, A. Aldrovandi, M. Francone, S. Desch, M. Gutberlet, O. Strohm, et al.
Clinical Characteristics and Cardiovascular Magnetic Resonance Findings in Stress (Takotsubo) Cardiomyopathy
JAMA,
July 20, 2011;
306(3):
277 - 286.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Mewton, C. Y. Liu, P. Croisille, D. Bluemke, and J. A. C. Lima
Assessment of Myocardial Fibrosis With Cardiovascular Magnetic Resonance
J. Am. Coll. Cardiol.,
February 22, 2011;
57(8):
891 - 903.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Iles, H. Pfluger, L. Lefkovits, M. J. Butler, P. M. Kistler, D. M. Kaye, and A. J. Taylor
Myocardial Fibrosis Predicts Appropriate Device Therapy in Patients With Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death
J. Am. Coll. Cardiol.,
February 15, 2011;
57(7):
821 - 828.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Nucifora, G. D. Aquaro, A. Pingitore, P. G. Masci, and M. Lombardi
Myocardial fibrosis in isolated left ventricular non-compaction and its relation to disease severity
Eur J Heart Fail,
February 1, 2011;
13(2):
170 - 176.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Harrigan, D. C. Peters, C. M. Gibson, B. J. Maron, W. J. Manning, M. S. Maron, and E. Appelbaum
Hypertrophic Cardiomyopathy: Quantification of Late Gadolinium Enhancement with Contrast-enhanced Cardiovascular MR Imaging
Radiology,
January 1, 2011;
258(1):
128 - 133.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Parsai and S. K. Prasad
21 Heart failure imaged by cardiac magnetic resonance imaging
Oxford Textbook of Heart Failure,
January 1, 2011;
1(1):
med-9780199577729-chapter - med-9780199577729-chapter.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. F. Azevedo, M. Nigri, M. L. Higuchi, P. M. Pomerantzeff, G. S. Spina, R. O. Sampaio, F. Tarasoutchi, M. Grinberg, and C. E. Rochitte
Prognostic Significance of Myocardial Fibrosis Quantification by Histopathology and Magnetic Resonance Imaging in Patients With Severe Aortic Valve Disease
J. Am. Coll. Cardiol.,
July 20, 2010;
56(4):
278 - 287.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Alpendurada, J. Wong, and D. J. Pennell
Practical applications of cardiovascular magnetic resonance
Heart Asia,
July 5, 2010;
1(1):
31 - 37.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. H. Rathod, A. Prakash, A. J. Powell, and T. Geva
Myocardial Fibrosis Identified by Cardiac Magnetic Resonance Late Gadolinium Enhancement Is Associated With Adverse Ventricular Mechanics and Ventricular Tachycardia Late After Fontan Operation
J. Am. Coll. Cardiol.,
April 20, 2010;
55(16):
1721 - 1728.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. H. Marwick, S. V. Raman, I. Carrio, and J. J. Bax
Recent Developments in Heart Failure Imaging
J. Am. Coll. Cardiol. Img.,
April 1, 2010;
3(4):
429 - 439.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Schalla, S. C. Bekkers, R. Dennert, R. J. van Suylen, J. Waltenberger, T. Leiner, J. Wildberger, H. J. Crijns, and S. Heymans
Replacement and reactive myocardial fibrosis in idiopathic dilated cardiomyopathy: comparison of magnetic resonance imaging with right ventricular biopsy
Eur J Heart Fail,
March 1, 2010;
12(3):
227 - 231.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Pennell
Cardiovascular Magnetic Resonance
Circulation,
February 9, 2010;
121(5):
692 - 705.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Gerson, M. Abdallah, J. N. Muth, and A. I. Costea
Will Imaging Assist in the Selection of Patients With Heart Failure for an ICD?
J. Am. Coll. Cardiol. Img.,
January 1, 2010;
3(1):
101 - 110.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M S Cocker, H Abdel-Aty, O Strohm, and M G Friedrich
Age and gender effects on the extent of myocardial involvement in acute myocarditis: a cardiovascular magnetic resonance study
Heart,
December 1, 2009;
95(23):
1925 - 1930.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Valle-Munoz, J. Estornell-Erill, C. J. Soriano-Navarro, M. Nadal-Barange, N. Martinez-Alzamora, F. Pomar-Domingo, M. Corbi-Pascual, R. Paya-Serrano, and F. Ridocci-Soriano
Late gadolinium enhancement-cardiovascular magnetic resonance identifies coronary artery disease as the aetiology of left ventricular dysfunction in acute new-onset congestive heart failure
Eur Heart J Cardiovasc Imaging,
December 1, 2009;
10(8):
968 - 974.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. D. Karamitsos, J. M. Francis, S. Myerson, J. B. Selvanayagam, and S. Neubauer
The Role of Cardiovascular Magnetic Resonance Imaging in Heart Failure
J. Am. Coll. Cardiol.,
October 6, 2009;
54(15):
1407 - 1424.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. H. Kwon, C. M. Halley, Z. B. Popovic, T. P. Carrigan, V. Zysek, R. Setser, P. Schoenhagen, S. D. Flamm, R. C. Starling, and M. Y. Desai
Gender differences in survival in patients with severe left ventricular dysfunction despite similar extent of myocardial scar measured on cardiac magnetic resonance
Eur J Heart Fail,
October 1, 2009;
11(10):
937 - 944.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Hombach, N. Merkle, J. Torzewski, J. M. Kraus, M. Kunze, O. Zimmermann, H. A. Kestler, and J. Wohrle
Electrocardiographic and cardiac magnetic resonance imaging parameters as predictors of a worse outcome in patients with idiopathic dilated cardiomyopathy
Eur. Heart J.,
August 2, 2009;
30(16):
2011 - 2018.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Flett, M. A. Westwood, L. C. Davies, A. Mathur, and J. C. Moon
The Prognostic Implications of Cardiovascular Magnetic Resonance
Circ Cardiovasc Imaging,
May 1, 2009;
2(3):
243 - 250.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. D. Roes, C. J. W. Borleffs, R. J. van der Geest, J. J.M. Westenberg, N. A. Marsan, T. A.M. Kaandorp, J. H.C. Reiber, K. Zeppenfeld, H. J. Lamb, A. de Roos, et al.
Infarct Tissue Heterogeneity Assessed With Contrast-Enhanced MRI Predicts Spontaneous Ventricular Arrhythmia in Patients With Ischemic Cardiomyopathy and Implantable Cardioverter-Defibrillator
Circ Cardiovasc Imaging,
May 1, 2009;
2(3):
183 - 190.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. M. Bogun, B. Desjardins, E. Good, S. Gupta, T. Crawford, H. Oral, M. Ebinger, F. Pelosi, A. Chugh, K. Jongnarangsin, et al.
Delayed-Enhanced Magnetic Resonance Imaging in Nonischemic Cardiomyopathy: Utility for Identifying the Ventricular Arrhythmia Substrate
J. Am. Coll. Cardiol.,
March 31, 2009;
53(13):
1138 - 1145.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. La Gerche, A. J. Taylor, and D. L. Prior
Athlete's Heart: The Potential for Multimodality Imaging to Address the Critical Remaining Questions
J. Am. Coll. Cardiol. Img.,
March 1, 2009;
2(3):
350 - 363.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Nazarian, D. A. Bluemke, and H. R. Halperin
Applications of Cardiac Magnetic Resonance in Electrophysiology
Circ Arrhythm Electrophysiol,
February 1, 2009;
2(1):
63 - 71.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N. DeMaria, O. Ben-Yehuda, J. J. Bax, G. K. Feld, B. H. Greenberg, W. Y.W. Lew, J. A.C. Lima, A. S. Maisel, S. M. Narayan, D. J. Sahn, et al.
Highlights of the Year in JACC 2008
J. Am. Coll. Cardiol.,
January 27, 2009;
53(4):
373 - 398.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Y. Kwong
Can cardiac magnetic resonance myocardial scar features affect treatment decisions for patients with coronary artery disease and heart failure?
J. Am. Coll. Cardiol. Img.,
January 1, 2009;
2(1):
45 - 47.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. G. Strauss, R. H. Selvester, J. A.C. Lima, H. Arheden, J. M. Miller, G. Gerstenblith, E. Marban, R. G. Weiss, G. F. Tomaselli, G. S. Wagner, et al.
ECG Quantification of Myocardial Scar in Cardiomyopathy Patients With or Without Conduction Defects: Correlation With Cardiac Magnetic Resonance and Arrhythmogenesis
Circ Arrhythm Electrophysiol,
December 1, 2008;
1(5):
327 - 336.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|